Emerging Strategies for Improving Outcomes in Patients With Inflammatory Airway Disease: Understanding the Role of IL-33
OMNI Hotel, Momentum D
Supported by an educational grant from AstraZeneca Pharmaceuticals.
OMNI Hotel, Momentum D
Supported by an educational grant from AstraZeneca Pharmaceuticals.
OMNI Hotel, Momentum EFG
Supported by an educational grant from Merck, Inc., and Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson & Johnson.
OMNI Hotel, Momentum ABC
Supported by an independent medical education grant from Jazz Pharmaceuticals.
Convention Center, Room 156
Supported by an educational grant from AstraZeneca Pharmaceuticals.
Convention Center, Room 157
Supported by an educational grant from Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson & Johnson, Merck & Co. Inc., and United Therapeutics, a public benefit company.
OMNI Hotel, Momentum ABC
Supported by an educational grant from GSK.
OMNI Hotel, Momentum D
Supported by an educational grant from Insmed.
OMNI Hotel, Momentum EFG
Supported by an educational grant from United Therapeutics, a public benefit company.
OMNI Hotel, Momentum EFG
Supported by an educational grant from AstraZeneca Pharmaceuticals.
OMNI Hotel, Momentum ABC
Supported by an educational grant from Insmed.
Subscribe below to get email updates from chestdailynews.chestnet.org